Signe Borgquist
41 – 50 of 171
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Neoadjuvant breast cancer treatment response; tumor size evaluation through different conventional imaging modalities in the NeoDense study
(
- Contribution to journal › Article
-
Mark
Effects of tumor-specific CAP1 expression and body constitution on clinical outcomes in patients with early breast cancer
(
- Contribution to journal › Article
-
Mark
Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors : a Danish population-based cohort study
(
- Contribution to journal › Article
-
Mark
Serum Iodine and Breast Cancer Risk : A Prospective Nested Case-Control Study Stratified for Selenium Levels
2020) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 29(7). p.1335-1340(
- Contribution to journal › Article
-
Mark
Prognostic Impact of Menopausal Hormone Therapy in Breast Cancer Differs According to Tumor Characteristics and Treatment
(
- Contribution to journal › Article
-
Mark
Re-evaluation of HER2 status in 606 breast cancers—gene protein assay on tissue microarrays versus routine pathological assessment
(
- Contribution to journal › Article
-
Mark
Investigating the risk of breast cancer among women exposed to chemicals : a nested case–control study using improved exposure estimates
(
- Contribution to journal › Article
-
Mark
Abstract P5-02-01: Analytical validation and prognostic potential of an automated digital scoring protocol for Ki67: An International Ki67 Working Group study
(
- Contribution to journal › Published meeting abstract
-
Mark
Hypoxia attenuates trastuzumab uptake and trastuzumab-emtansine (T-DM1) cytotoxicity through redistribution of phosphorylated caveolin-1
(
- Contribution to journal › Article
-
Mark
CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients
(
- Contribution to journal › Article